Rating Change
Leerink Partners reiterated its Market Perform rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) on November 05, 2026.
reiterateNASDAQ:PRCT
Leerink Partners Reiterates Market Perform Rating on PROCEPT BioRobotics Corporation (PRCT)
Leerink Partners reiterated its Market Perform rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) on November 05, 2026.
At publication ·
What changed
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) · reiterate
- Firm
- Leerink Partners
- Rating
- Market Perform to Market Perform
- Price at event
- $20.27
- Market capitalization
- $2.0B
At a glance
Key takeaways
- PRCT stock trades at $20.27 with a $2.0B market cap and has fallen 37.2% over the past 52 weeks.
Market Context
PROCEPT BioRobotics Corporation operates in the Healthcare sector. The stock currently trades at $20.27 with a market capitalization of $2.0B. The stock has declined 37.2% over the past 52 weeks.
Analyst coverage from Leerink Partners provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for PROCEPT BioRobotics Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for PROCEPT BioRobotics Corporation
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 05, 2026 | Leerink Partners | Market Perform | N/A |
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Aug 05, 2026 | William Blair | Market Perform | N/A |
| Aug 05, 2026 | Piper Sandler | Overweight | N/A |
| Aug 05, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PRCT Stock Page
Frequently Asked Questions
What does the Market Perform rating mean for PRCT?
A rating of Market Perform from Leerink Partners reflects the analyst's outlook on PROCEPT BioRobotics Corporation (NASDAQ:PRCT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PRCT forecast page.